Patents by Inventor Tore Bach-Gansmo

Tore Bach-Gansmo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMAGING OF METASTATIC OR RECURRENT CANCER
    Publication number: 20210290783
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC, The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Application
    Filed: February 26, 2021
    Publication date: September 23, 2021
    Applicant: Blue Earth Diagnostics Limited
    Inventors: Matthew MILLER, David GAUDEN, David SCHUSTER, Stefano FANTI, Cristina NANNI, Lucia ZANONI, Frode WILLOCH, Trond Velde BOGSRUD, Tore BACH-GANSMO, Alessandra MUSTO
  • Imaging of metastatic or recurrent cancer
    Patent number: 10967077
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: April 6, 2021
    Assignee: Blue Earth Diagnostics Limited
    Inventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Velde Bogsrud, Tore Bach-Gansmo, Alessandra Musto
  • Imaging of metastatic or recurrent cancer
    Patent number: 10933147
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: March 2, 2021
    Assignee: Blue Earth Diagnostics Limited
    Inventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Bogsrud, Tore Bach-Gansmo, Alessandra Musto
  • IMAGING OF METASTATIC OR RECURRENT CANCER
    Publication number: 20200316228
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Applicant: Blue Earth Diagnostics Limited
    Inventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Bogsrud, Tore Bach-Gansmo, Alessandra Musto
  • IMAGING OF METASTATIC OR RECURRENT CANCER
    Publication number: 20200316227
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Applicant: Blue Earth Diagnostics Limited
    Inventors: Matthew MILLER, David GAUDEN, David SCHUSTER, Stefano FANTI, Cristina NANNI, Lucia ZANONI, Frode WILLOCH, Trond BOGSRUD, Tore BACH-GANSMO, Alessandra MUSTO
  • Imaging of metastatic or recurrent cancer
    Patent number: 10716868
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 21, 2020
    Assignee: Blue Earth Diagnostics Limited
    Inventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Velde Bogsrud, Tore Bach-Gansmo, Alessandra Musto
  • Imaging of metastatic or recurrent cancer
    Patent number: 10124079
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: November 13, 2018
    Assignee: Blue Earth Diagnostics Limited
    Inventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Velde Bogsrud, Tore Bach-Gansmo, Alessandra Musto
  • Parenteral administration of positive and negative contrast agents for MRI
    Patent number: 6045775
    Abstract: This invention relates to improvements in and relating to magnetic resonance imaging of the human or non-human body. The invention particularly relates to a method in which positive and negative contrast agents are administered to enhance image contrast.
    Type: Grant
    Filed: February 26, 1998
    Date of Patent: April 4, 2000
    Assignee: Nycomed Imaging AS
    Inventors: Anders Ericcson, Anne Kjersti Fahlvik, Anders Hemmingsson, Mats Wikstrom, Audun ksendal, Tore Bach-Gansmo
  • Composition for MRI comprising both a positive and a negative contrast agent
    Patent number: 5869023
    Abstract: This invention relates to improvements in and relating to magnetic resonance imaging of the human or non-human body. The invention particularly relates to a method in which positive and negative contrast agents are administered to enhance image contrast.
    Type: Grant
    Filed: January 26, 1996
    Date of Patent: February 9, 1999
    Assignee: Nycomed Imaging AS
    Inventors: Anders Ericcson, Anne Kjersti Fahlvik, Anders Hemmingsson, Mats Wikstrom, Audun ksendal, Tore Bach-Gansmo